UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung Journal article
Hao, Mengyao, Fu, Rong, Tai, Jun, Tian, Zhenhuan, Yuan, Xia, Chen, Yang, Wang, Mingjin, Jiang, Huimin, Ji, Ming, Lai, Fangfang, Xue, Nina, Bai, Liping, Zhu, Yizhun, Lv, Xiaoxi, Chen, Xiaoguang, Jin, Jing. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung[J]. Acta Pharmaceutica Sinica B, 2022, 13(3), 1110-1127.
Authors:  Hao, Mengyao;  Fu, Rong;  Tai, Jun;  Tian, Zhenhuan;  Yuan, Xia; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:14.7/14.1 | Submit date:2023/01/30
Endothelial Barrier  Fty720  Idiopathic Pulmonary Fibrosis  Immh002  Protein Stability  Sphingosine-1-phosphate Receptor 1  Sphingosine-1-phosphate Receptor 1 Agonist  Tight Junction